{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:17Z","timestamp":1793066297465,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2022QH2037"],"award-info":[{"award-number":["2022QH2037"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271326"],"award-info":[{"award-number":["82271326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the First Affiliated Hospital of Fujian Medical University","award":["2023YSJYX-ZD-1"],"award-info":[{"award-number":["2023YSJYX-ZD-1"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2024CXA017"],"award-info":[{"award-number":["2024CXA017"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113950","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:10:57Z","timestamp":1749557457000},"page":"113950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Targeting ferroptosis and mitophagy with neutrophil-inspired nanozyme for Parkinson's disease therapy"],"prefix":"10.1016","volume":"384","author":[{"given":"Yu","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113950_bb0005","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.113950_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-071322-021330","article-title":"Polyamines in Parkinson\u2019s disease: balancing between neurotoxicity and neuroprotection","volume":"92","author":"Vrijsen","year":"2023","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jconrel.2025.113950_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.jconrel.2025.113950_bb0020","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2025.113950_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jconrel.2025.113950_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404576","article-title":"Black phosphorus nanosheets protect neurons by degrading aggregative \u03b1-syn and clearing ROS in Parkinson\u2019s disease","volume":"36","author":"He","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113950_bb0035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.10.004","article-title":"The glutathione system in Parkinson\u2019s disease and its progression","volume":"120","author":"Bj\u00f8rklund","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jconrel.2025.113950_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154757","article-title":"Involvement of antioxidant enzymes in Parkinson\u2019s disease","volume":"249","author":"Tahavvori","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jconrel.2025.113950_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin protects against MPP+\/MPTP-induced dopaminergic neuron death in Parkinson\u2019s disease by inhibiting ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2025.113950_bb0050","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1038\/s41467-023-38323-w","article-title":"In situ continuous Dopa supply by responsive artificial enzyme for the treatment of Parkinson\u2019s disease","volume":"14","author":"Fang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113950_bb0055","article-title":"Antioxidant therapy in Parkinson\u2019s disease: insights from Drosophila melanogaster","volume":"9","author":"De Lazzari","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jconrel.2025.113950_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202308814","article-title":"Engineering of therapeutic and detoxifying enzymes","volume":"135","author":"Michailidou","year":"2023","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2025.113950_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407816","article-title":"Safety landscape of therapeutic nanozymes and future research directions","volume":"11","author":"Tagaras","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113950_bb0070","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1021\/acsnano.3c04378","article-title":"Rational design strategies for nanozymes","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113950_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106723","article-title":"Prussian blue nanozyme as a pyroptosis inhibitor alleviates neurodegeneration","volume":"34","author":"Ma","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113950_bb0080","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acsami.4c17416","article-title":"Synergistic Co\u2013Cu dual-atom nanozyme with promoted catalase-like activity for Parkinson\u2019s disease treatment","volume":"17","author":"Wang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113950_bb0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s12951-024-02924-4","article-title":"Single-atom nanozyme liposome-integrated microneedles for in situ drug delivery and anti-inflammatory therapy in Parkinson's disease","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113950_bb0090","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/jacs.8b11856","article-title":"Chiral molecule-mediated porous Cu x O nanoparticle clusters with antioxidation activity for ameliorating Parkinson\u2019s disease","volume":"141","author":"Hao","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113950_bb0095","doi-asserted-by":"crossref","first-page":"47482","DOI":"10.1021\/acsomega.3c04312","article-title":"Polyvinylpyrrolidone-capped copper oxide nanoparticles-anchored pramipexole attenuates the rotenone-induced phenotypes in a Drosophila Parkinson\u2019s disease model","volume":"8","author":"Hanumanthappa","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2025.113950_bb0100","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1166\/jnn.2021.18636","article-title":"Explore the effects of Fe3O4 nanoparticles and oxidative stress and neuroinflammatory responses on the intestinal flora based on a Parkinson rat model","volume":"21","author":"Xu","year":"2021","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113950_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202405190","article-title":"Emerging nanozymes in neurological disorder therapeutics: bridging oxidoreductase mimicry and antioxidant chemistry","volume":"34","author":"Jiang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113950_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106506","article-title":"Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson\u2019s disease","volume":"196","author":"Buoso","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2025.113950_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.arr.2004.01.003","article-title":"Does cellular iron dysregulation play a causative role in Parkinson\u2019s disease?","volume":"3","author":"Kaur","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jconrel.2025.113950_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-024-02071-0","article-title":"Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113950_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107054","article-title":"Guiding transition metal-doped hollow cerium tandem nanozymes with elaborately regulated multi-enzymatic activities for intensive chemodynamic therapy","volume":"34","author":"Dong","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113950_bb0130","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1038\/s41467-024-50344-7","article-title":"Elucidating the catalytic mechanism of Prussian blue nanozymes with self-increasing catalytic activity","volume":"15","author":"Feng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113950_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1981","article-title":"Nanozymes for biomedical applications: multi-metallic systems may improve activity but at the cost of higher toxicity?","volume":"16","author":"Phan-Xuan","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113950_bb0140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mds.27275","article-title":"Iron as a therapeutic target for Parkinson\u2019s disease","volume":"33","author":"Moreau","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jconrel.2025.113950_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00702-019-02138-1","article-title":"Conservative iron chelation for neurodegenerative diseases such as Parkinson\u2019s disease and amyotrophic lateral sclerosis","volume":"127","author":"Devos","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jconrel.2025.113950_bb0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acs.biomac.6b01547","article-title":"Iron chelation nanoparticles with delayed saturation as an effective therapy for Parkinson disease","volume":"18","author":"Wang","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.113950_bb0155","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","article-title":"Benefits of iron chelators in the treatment of Parkinson\u2019s disease","volume":"46","author":"Zeng","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2025.113950_bb0160","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in Parkinson\u2019s disease","volume":"387","author":"Devos","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.113950_bb0165","article-title":"Icariside II relieves radiation enteritis by regulating PINK\/parkin-mediated mitophagy","volume":"146","author":"He","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.113950_bb0170","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s42003-024-06896-x","article-title":"Human \u03b1-synuclein aggregation activates ferroptosis leading to parvalbumin interneuron degeneration and motor learning impairment","volume":"7","author":"Zhang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2025.113950_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103074","article-title":"New insights on neurodegeneration triggered by iron accumulation: intersections with neutral lipid metabolism, ferroptosis, and motor impairment","volume":"71","author":"Maniscalchi","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2025.113950_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102477","article-title":"Ferroptosis in Parkinson\u2019s disease \u2013 the iron-related degenerative disease","volume":"101","author":"Yao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jconrel.2025.113950_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094654","article-title":"The importance and essentiality of natural and synthetic chelators in medicine: increased prospects for the effective treatment of iron overload and iron deficiency","volume":"25","author":"Kontoghiorghes","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.113950_bb0190","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1474-4422(23)00039-X","article-title":"Iron chelation in early Parkinson\u2019s disease","volume":"22","author":"Levi","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2025.113950_bb0195","article-title":"Neutrophil membrane-camouflaged polyprodrug nanomedicine for inflammation suppression in ischemic stroke therapy","volume":"36","author":"Zhao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113950_bb0200","series-title":"Exploration","first-page":"20210115","article-title":"Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases","author":"Zhang","year":"2021"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592500570X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592500570X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:45:23Z","timestamp":1779511523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592500570X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"alternative-id":["S016836592500570X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113950","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ferroptosis and mitophagy with neutrophil-inspired nanozyme for Parkinson's disease therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113950"}}